Analyst Recommendations
14.99 0.13(0.87%)09/13/2024
Entrada Therapeutics Inc (TRDA)
Entrada Therapeutics Inc (TRDA)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 3 |
Outperform | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades